$3.51
arrow_drop_up1.44%Key Stats | |
---|---|
Open | $3.47 |
Prev. Close | $3.46 |
EPS | -0.43 |
Dividend | Non-Dividend |
Next Earnings Date | - |
Dividend Yield % | - |
Market Cap | $662.62M |
PE Ratio | - |
LOW | HIGH | |
---|---|---|
Day Range | 3.41 | 3.56 |
52 Week Range | 1.69 | 4.72 |
Ratios | |
---|---|
EPS | -0.43 |
Don't miss out on the opportunity to stay ahead in the ever-changing world of finance.
Period: Next 12 Months
•Adding the right stocks to your watchlist can provide valuable insights and opportunities for strategic decision-making.
Ultragenyx (RARE) Moves 7.8% Higher: Will This Strength Last?
Treatment with Arbutus’ Imdusiran and VTP-300 Achieves Statistical Significance in Lowering HBsAg Levels
Arbutus’ Imdusiran with Short Course Interferon Achieves Sustained Undetectable HBsAg, a Necessity for HBV Functional Cure
Arbutus to Participate in Jefferies Global Healthcare Conference
Arbutus to Present Imdusiran Data at EASL Congress 2024
Arbutus to Participate in Two Upcoming Investor Conferences